Breast and Gynecologic Cancer

The Breast and Gynecologic Cancer Research Group conducts and fosters the development of research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and precursor conditions related to these cancers.

Read more About the Breast and Gynecologic Cancer Research Group.

Staff

Funding Opportunities

Grants

Clinical Trials

Publications

Cancer Prevention Clinical Trials Network (CP-CTNet)

Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.

HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network

Seeks to conduct pragmatic clinical trials evaluating the effectiveness of clinically proven interventions to optimize the cervical cancer screening, management, and precancer treatment cascade for WLWH.

The National Cancer Institute (NCI)’s Cervical Cancer ‘Last Mile’ Initiative

The 'Last Mile'  is a public-private partnership bringing together federal agencies, industry partners, and professional societies to contribute evidence about the accuracy and clinical effectiveness of self-sampling-based HPV testing for cervical cancer screening.

Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Major medical research centers conduct systematic early clinical development of promising preventive agents.

US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)

Partnership Centers will focus on improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals.

News and Events

Acting Chief of Community Oncology and Prevention Trials Research Group Named
Date Posted: November 1, 2023

Research Highlights: Repurposing Common Medications to Prevent Cancer
Date Posted: September 11, 2023

Cancer Healthcast: NCI ‘Last Mile’ Initiative Innovates Self-Sampling for HPV Screening
Date Posted: July 31, 2023

U.S. Study Shows HPV Antibodies Remain High Up to 2 Years After a Single Dose of HPV Vaccine
Date Posted: July 18, 2023

When Prenatal DNA Tests Point to Cancer
Date Posted: May 17, 2023